CLOVER HEALTH INVESTMENTS, CORP. /DE vs CENTENE CORPORATION, two Managed Care stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where CLOV and CNC diverge most: on debt / equity, CLOV reads 0.00 and CNC reads 0.71; on fcf yield, CLOV reads 2.8% and CNC reads 27.1%. The rest of the comparable metrics sit closer together. The bull and bear cases for each are in their full reports below.
| Metric | CLOV | CNC |
|---|---|---|
| Price | $4.83 | $66.40 |
| Market cap | $2.6B | $33.0B |
| Sector | Managed Care | Managed Care |
| Stage | Growth | Growth |
| P/B | 7.00 | 1.46 |
| P/S | 1.06 | 0.16 |
| EV/EBITDA | 60.9 | 7.7 |
| Revenue growth | +53.1% | +14.3% |
| Gross margin | — | 8.6% |
| Operating margin | 3.8% | 2.2% |
| Net margin | -0.7% | -2.5% |
| Return on equity | -4.9% | -22.5% |
| Return on assets | -2.5% | -6.1% |
| Return on invested capital | 8.7% | 3.7% |
| FCF yield | 2.8% | 27.1% |
| Debt / equity | 0.00 | 0.71 |
| Current ratio | 1.50 | 1.15 |
| Altman Z (solvency) | 4.09 | 3.10 |
| Piotroski F (quality) | 5 / 9 | 6 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.